• Citer

Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats.

par Oumeiri, Bachar El;McEntee, Kathleen ;Annoni, Filippo ;Herpain, Antoine ;Vanden Eynden, Frédéric ;Jespers, Pascale ;Van Nooten, Guido ;Van De Borne, Philippe
Référence BMC cardiovascular disorders, 18, 1, page (99)
Publication Publié, 2018-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats.
Auteur:	Oumeiri, Bachar El; McEntee, Kathleen; Annoni, Filippo; Herpain, Antoine; Vanden Eynden, Frédéric; Jespers, Pascale; Van Nooten, Guido; Van De Borne, Philippe
Informations sur la publication:	BMC cardiovascular disorders, 18, 1, page (99)
Statut de publication:	Publié, 2018-05
Sujet CREF:	Sciences bio-médicales et agricoles
	Cardiologie et circulation
Mots-clés:	Aortic regurgitation
	Doppler-echocardiography
	Left ventricle
	Omecamtiv-mecarbil
	Wistar rat
MeSH keywords:	Animals
	Aortic Valve -- diagnostic imaging -- drug effects -- metabolism -- physiopathology
	Aortic Valve Insufficiency -- diagnostic imaging -- drug therapy -- metabolism -- physiopathology
	Cardiac Myosins -- metabolism
	Cardiovascular Agents -- administration & dosage
	Chronic Disease
	Disease Models, Animal
	Echocardiography, Doppler
	Hemodynamics -- drug effects
	Infusions, Intravenous
	Male
	Rats, Wistar
	Recovery of Function
	Severity of Illness Index
	Stroke Volume -- drug effects
	Urea -- administration & dosage -- analogs & derivatives
	Ventricular Function, Left -- drug effects
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1471-2261
	info:doi/10.1186/s12872-018-0831-3
	info:pii/10.1186/s12872-018-0831-3
	info:scp/85047330440
	info:pmid/29783950
	PMC5963065